138 related articles for article (PubMed ID: 10942409)
1. Hydroxyurea-induced marked oscillations of platelet counts in patients with polycythemia vera.
Tefferi A; Elliott MA; Kao PC; Yoon S; El-Hemaidi I; Pearson TC
Blood; 2000 Aug; 96(4):1582-4. PubMed ID: 10942409
[TBL] [Abstract][Full Text] [Related]
2. Hydroxyurea-associated platelet count oscillations in polycythemia vera: a report of four new cases and a review.
Steensma DP; Harrison CN; Tefferi A
Leuk Lymphoma; 2001; 42(6):1243-53. PubMed ID: 11911405
[TBL] [Abstract][Full Text] [Related]
3. Cyclic thrombocytopenia and polycythemia vera.
Kojima K; Fujii N; Omoto E; Nose S; Yoneyama M; Sugii Y; Hiramatsu H; Chikatsune M; Sato M; Takata S; Itoshima T; Tanimoto M
Ann Hematol; 2003 Jan; 82(1):61-3. PubMed ID: 12574969
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukemia occurring in a patient with polycythemia vera in treatment with hydroxyurea.
Cacciola E; Cacciola RR; Guglielmo P; Stagno F; Giustolisi R
Haematologica; 1999 Aug; 84(8):755-6. PubMed ID: 10457418
[No Abstract] [Full Text] [Related]
5. Polycythaemia vera: bone marrow histopathology under treatment with interferon, hydroxyurea and busulphan.
Kreft A; Nolde C; Büsche G; Buhr T; Kreipe H; Georgii A
Eur J Haematol; 2000 Jan; 64(1):32-41. PubMed ID: 10680703
[TBL] [Abstract][Full Text] [Related]
6. How safe is hydroxyurea in the treatment of polycythemia vera?
Haematologica; 1999 Aug; 84(8):673-4. PubMed ID: 10457399
[No Abstract] [Full Text] [Related]
7. Cutaneous effects after prolongaded use of hydroxyurea in Polycythemia Vera.
França ER; Teixeira MA; Matias Kde F; Antunes DE; Braz Rde A; Silva CE
An Bras Dermatol; 2011; 86(4):751-4. PubMed ID: 21987143
[TBL] [Abstract][Full Text] [Related]
8. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera.
Moliterno AR; Hankins WD; Spivak JL
N Engl J Med; 1998 Feb; 338(9):572-80. PubMed ID: 9475764
[TBL] [Abstract][Full Text] [Related]
9. A novel thrombopoietin signaling defect in polycythemia vera platelets.
Moliterno AR; Siebel KE; Sun AY; Hankins WD; Spivak JL
Stem Cells; 1998; 16 Suppl 2():185-92. PubMed ID: 11012190
[TBL] [Abstract][Full Text] [Related]
10. Megakaryocyte precursors (pro- and megakaryoblasts) in bone marrow tissue from patients with reactive thrombocytosis, polycythemia vera and primary (essential) thrombocythemia. An immunomorphometric study.
Thiele J; Wagner S; Degel C; Dienemann D; Wienhold S; Zankovich R; Fischer R; Stein H
Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 58(4):295-302. PubMed ID: 1970693
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyurea-induced stomatocytes in a patient presenting with polycythemia vera.
Perrin J; Ranta D; Lesesve JF
Am J Hematol; 2015 Jun; 90(6):573. PubMed ID: 25545052
[No Abstract] [Full Text] [Related]
12. Hydroxycarbamide associated platelet count oscillations in a patient with polycythaemia vera. A case report and review of the literature.
Burthem J; Chaudhry MS
Platelets; 2008 May; 19(3):234-5. PubMed ID: 18432524
[TBL] [Abstract][Full Text] [Related]
13. Treatment of polycythemia vera with hydroxyurea.
Donovan PB; Kaplan ME; Goldberg JD; Tatarsky I; Najean Y; Silberstein EB; Knospe WH; Laszlo J; Mack K; Berk PD
Am J Hematol; 1984; 17(4):329-34. PubMed ID: 6496458
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of hydroxyurea transporters in normal and polycythemia vera hematopoietic stem and progenitor cell subpopulations.
Tan G; Meier-Abt F
Exp Hematol; 2021 May; 97():47-56.e5. PubMed ID: 33677043
[TBL] [Abstract][Full Text] [Related]
15. Marked heterogeneity in protein levels and functional integrity of the thrombopoietin receptor c-mpl in polycythaemia vera.
Le Blanc K; Andersson P; Samuelsson J
Br J Haematol; 2000 Jan; 108(1):80-5. PubMed ID: 10651727
[TBL] [Abstract][Full Text] [Related]
16. Complex karyotype in a polycythemia vera patient with a novel SETD1B/GTF2H3 fusion gene.
Tiziana Storlazzi C; Pieri L; Paoli C; Daniele G; Lasho T; Tefferi A; Vannucchi AM
Am J Hematol; 2014 Apr; 89(4):438-42. PubMed ID: 24382738
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyurea therapy increases plasma erythropoietin in patients with essential thrombocythaemia or polycythaemia vera.
Johansson P; Andréasson B
Clin Lab Haematol; 2006 Aug; 28(4):233-6. PubMed ID: 16898960
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG.
Michiels JJ; Barbui T; Finazzi G; Fuchtman SM; Kutti J; Rain JD; Silver RT; Tefferi A; Thiele J
Leuk Lymphoma; 2000 Jan; 36(3-4):239-53. PubMed ID: 10674896
[TBL] [Abstract][Full Text] [Related]
19. Polycythemia vera and hydroxyurea resistance/intolerance: a monocentric retrospective analysis.
Demuynck T; Verhoef G; Delforge M; Vandenberghe P; Devos T
Ann Hematol; 2019 Jun; 98(6):1421-1426. PubMed ID: 30919072
[TBL] [Abstract][Full Text] [Related]
20. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Nand S; Stock W; Godwin J; Fisher SG
Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
